Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
CANbridge Pharmaceuticals Inc. ( (HK:1228) ) has shared an announcement.
CANbridge Pharmaceuticals Inc. has announced the composition of its board of directors and their respective roles within the company. This update highlights the leadership structure and the committees each director is involved in, reflecting the company’s commitment to strong governance and strategic oversight.
More about CANbridge Pharmaceuticals Inc.
CANbridge Pharmaceuticals Inc. is a biopharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative therapies for rare diseases and targeted cancers.
Average Trading Volume: 5,299,196
Technical Sentiment Signal: Sell
Current Market Cap: HK$119M
For an in-depth examination of 1228 stock, go to TipRanks’ Overview page.